Výsledky vyhledávání

Akademický článek

A Senescence-Mimicking (Senomimetic) VEGFR TKI Side Effect Primes Tumor Immune Responses via IFN/STING Signaling.

Autor: Dolan M; Department of Experimental Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, New York., Shi Y; Department of Experimental Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, New York., Mastri M; Department of Cancer Genetics and Genomics, Roswell Park Comprehensive Cancer Center, Buffalo, New York., Long MD; Department of Bioinformatics and Statistics, Roswell Park Comprehensive Cancer Center, Buffalo, New York., McKenery A; Department of Cancer Genetics and Genomics, Roswell Park Comprehensive Cancer Center, Buffalo, New York., Hill JW; Jacobs School of Medicine and Biomedical Sciences, SUNY at Buffalo, Buffalo, New York., Vaghi C; Inria Team MONC, Inria Bordeaux Sud-Ouest, Talence, France.; Computational Pharmacology and Clinical Oncology (COMPO), Inria Sophia Antipolis-Méditerranée, Cancer Research Center of Marseille, Inserm UMR1068, CNRS UMR7258, Aix Marseille University UM105, Marseille, France., Benzekry S; Inria Team MONC, Inria Bordeaux Sud-Ouest, Talence, France.; Computational Pharmacology and Clinical Oncology (COMPO), Inria Sophia Antipolis-Méditerranée, Cancer Research Center of Marseille, Inserm UMR1068, CNRS UMR7258, Aix Marseille University UM105, Marseille, France., Barbi J; Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, New York., Ebos JML; Department of Experimental Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, New York.; Department of Cancer Genetics and Genomics, Roswell Park Comprehensive Cancer Center, Buffalo, New York.; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York.

Publikováno v: Molecular cancer therapeutics [Mol Cancer Ther] 2024 Jun 19, pp. OF1-OF20. Date of Electronic Publication: 2024 Jun 19.

Zobrazit plný text záznamu

Akademický článek

Machine-learning and mechanistic modeling of metastatic breast cancer after neoadjuvant treatment.

Autor: Benzekry S; Computational Pharmacology and Clinical Oncology (COMPO), Inria Sophia Antipolis-Méditerranée, Cancer Research Center of Marseille, Inserm UMR1068, CNRS UMR7258, Aix Marseille University UM105, Marseille, France., Mastri M; Department of Cancer Genetics and Genomics, Roswell Park Comprehensive Cancer Center, Buffalo, New York, United States of America., Nicolò C; InSilicoTrials Technologies S.P.A, Riva Grumula, Trieste, Italy., Ebos JML; Department of Cancer Genetics and Genomics, Roswell Park Comprehensive Cancer Center, Buffalo, New York, United States of America.; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York, United States of America.

Publikováno v: PLoS computational biology [PLoS Comput Biol] 2024 May 03; Vol. 20 (5), pp. e1012088. Date of Electronic Publication: 2024 May 03 (Print Publication: 2024).

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

A phase I/II study of nintedanib and capecitabine for refractory metastatic colorectal cancer.

Autor: Boland PM; Department of Medical Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Ebos JML; Department of Cancer Genetics and Genomics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Attwood K; Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Mastri M; Department of Cancer Genetics and Genomics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Fountzilas C; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Iyer RV; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Banker C; Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Goey AKL; Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Bies R; Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, Buffalo, NY, USA., Ma WW; Department of Hematology and Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Fakih M; Department of Medicine, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.

Publikováno v: JNCI cancer spectrum [JNCI Cancer Spectr] 2024 Apr 30; Vol. 8 (3).

Zobrazit plný text záznamu

Akademický článek

Downregulation of IRF8 in alveolar macrophages by G-CSF promotes metastatic tumor progression.

Autor: Tzetzo SL; Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA., Kramer ED; Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA., Mohammadpour H; Department of Cell Stress Biology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA., Kim M; Department of Surgical Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA., Rosario SR; Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA., Yu H; Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA., Dolan MR; Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA., Oturkar CC; Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA., Morreale BG; Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA., Bogner PN; Department of Pathology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA., Stablewski AB; Department of Molecular and Cellular Biology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA., Benavides FJ; Department of Epigenetics and Molecular Carcinogenesis, MD Anderson Cancer Center, Houston, TX 77030, USA., Brackett CM; Department of Cell Stress Biology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA., Ebos JML; Department of Cancer Genetics and Genomics, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA., Das GM; Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA., Opyrchal M; Department of Medicine, Indiana University, Indianapolis, IN 46202, USA., Nemeth MJ; Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA., Evans SS; Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA., Abrams SI; Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.

Publikováno v: IScience [iScience] 2024 Feb 10; Vol. 27 (3), pp. 109187. Date of Electronic Publication: 2024 Feb 10 (Print Publication: 2024).

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání